Preferred Pharmaceuticals, Inc recalls Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06), M
Recalled December 18, 2019 · FDA recall D-0617-2020 · Preferred Pharmaceuticals
Hazard
CGMP Deviations: Presence of NDMA impurity detected in product. · FDA Class II
Units
316 bottles
Sold at
CA, FL
Description
CGMP Deviations: Presence of NDMA impurity detected in product.
Product
Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06), Mfg: Amneal Pharmaceuticals
Manufacturer(s)
Preferred Pharmaceuticals, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →